Alpha Signal Monitor - Daily Market Briefing | November 20, 2025
Daily Market Research Report
November 20, 2025
Alpha Signal Monitor
Welcome to your daily pre-market briefing. This report provides key insights on market opportunities and analyst perspectives to help identify potential alpha signals.
Today's Coverage: - Gold ETF Outlook: Institutional perspectives on gold-backed ETFs - Stock Ratings: Latest analyst ratings and target prices for our watchlist - IPO Calendar: Upcoming initial public offerings and market debuts
Watchlist Stocks: AAPL, MSFT, GOOGL, AMZN, NVDA, META, TSLA, AVGO, TSM
This report is generated using advanced AI research capabilities with real-time market data access.
Institutional outlook on GLD/IAU/BAR (as of 2025-11-20)
Trading Idea: Buy Rationale (TL;DR): Consensus across major houses tilts bullish into 2026 on sustained central-bank buying, returning ETF inflows, and an easier Fed, with several banks now flagging $4,500–$5,000/oz scenarios. Physically backed ETFs (GLD/IAU/BAR) provide the cleanest exposure to this thesis.
2025’s rally has been driven by policy/geopolitical risks and a turn toward Fed easing, while official-sector demand remains exceptional and ETF flows have re-accelerated; multiple houses now see scope for fresh highs into 2026 despite pullbacks.
Key Drivers - Robust official-sector (central bank) purchases expected near 900–1,000t in 2025, led by diversification and de‑dollarization trends. - Improving ETF demand alongside Fed rate‑cut cycle lowers gold’s opportunity cost and supports flows. - Policy uncertainty (tariffs, Fed independence concerns) and elevated geopolitics keep safe‑haven bid in place. - Most banks now model higher 2026 price decks ($4,000–$5,000), reinforcing positive medium‑term expected returns. - Limited supply responsiveness (permitting, capex constraints) tempers downside from mine growth.
| Institution | Stance | Price View | Key Evidence | Last Update | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Bullish | $4,900/oz by Dec 2026; earlier mid‑2026 baseline ~ $4,000/oz | GS reiterates a structurally bullish view on strong official buying and returning ETF inflows; latest media reports cite a $4,900/oz target by Dec 2026, while GS Research (Sep 30) outlined $4,000 by mid‑2026 with central‑bank demand and Fed easing as pillars. | 2025-11-19 | - |
| Morgan Stanley | Positive | $4,400/oz by end‑2026 | MS Research expects the rally to continue, revising its 2026 forecast to ~$4,400/oz; highlights central‑bank/ETF demand and a weaker USD, while noting risks from demand destruction and softer jewelry consumption. | 2025-10-22 | - |
| JP Morgan | Positive | Avg $3,675/oz in Q4‑2025; toward ~$4,000/oz by mid‑2026 | JPM Global Commodities Strategy remains structurally constructive, citing ~710t/quarter combined investor and CB demand in 2025 and viewing gold as an optimal hedge against stagflation/policy risks. | 2025-06-10 | - |
| Bank of America | Bullish | $5,000/oz in 2026 (avg ~$4,400/oz) | BofA Global Research lifted its 2026 target to $5,000/oz after gold broke $4,000, arguing a ~14% investment‑demand increase could propel prices; acknowledges scope for a near‑term correction. | 2025-10-13 | - |
| Citigroup | Cautious/Neutral | 0–3M: $3,800/oz (cut from $4,000); previously flagged sub‑$3,000 risk into late‑2025/2026 | Citi trimmed near‑term targets on Oct 28, 2025 amid easing uncertainty and weaker momentum; earlier in June it warned prices could slip below $3,000 by late‑2025/early‑2026 on fading investment demand and better growth. | 2025-10-28 | - |
| UBS | Overweight/Most Preferred | Base case lifted to $3,500/oz across forecast horizons; upside $3,800/oz | UBS CIO raised gold to Most Preferred with a $3,500/oz target across tenors (Apr 11, 2025), citing structural allocation shifts (e.g., China insurers), ~1,000t CB buying in 2025, and rising ETF demand; maintains ~5% portfolio allocation guidance. | 2025-04-11 | - |
| HSBC | Bullish | Peak ~$5,000/oz in 1H‑2026; 2025 avg $3,455; 2026 avg $4,600 | HSBC sees a ‘bull wave’ into 1H‑2026 on geopolitics, policy uncertainty, CB buying and ETF inflows; notes volatility and potential moderation later in 2026. | 2025-10-17 | - |
| Deutsche Bank | Positive | 2026 average raised to $4,000/oz; sees upside risks > correction risk | DB lifted its 2026 average to $4,000/oz, citing strong official demand (running ~2x 2011–21 average), possible USD weakness, and Fed easing; flags risks from seasonal weakness and equities strength. | 2025-09-17 | - |
Risk Considerations - Stronger USD or higher real yields could sap momentum and pressure ETF flows. - Demand destruction at elevated prices (jewelry softness; central banks buying less at highs). - De‑escalation of trade/geopolitical tensions and firmer global growth could reduce safe‑haven demand. - Volatility/near‑term corrections flagged even by bulls (timing risk for entries).
Position core exposure in GLD/IAU/BAR as strategic hedges; add on pullbacks given a supportive 2026 setup across most banks. Use sizing/stop discipline given near‑term volatility and sensitivity to USD/real‑rate swings; reassess if official‑sector demand slows materially or policy risks fade.
Stock Ratings — Street targets and ratings from GS, MS, JPM, BAC, Citi, and WFC
Compiled using the latest publicly available notes as of November 20, 2025. Company names corrected where needed: AVGO is Broadcom Inc.; TSM is Taiwan Semiconductor Manufacturing Company (TSMC). Targets are reported in the institution’s quoted currency. “Overweight/Outperform” mapped to “Buy,” “Equal Weight/Market Perform” to “Hold,” and “Underweight/Sell” to “Sell.”
AAPL - Apple Inc.
Broad-based Buy/Overweight stance; several firms lifted targets into October 2025 on Services/App Store strength and AI expectations.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $320 | 2025-10-31 | Raised PT; reiterated Buy on App Store/AI momentum. | https://www.gurufocus.com/news/3175717/goldman-sachs-raises-price-target-for-apple-aapl-to-320-aapl-stock-news |
| Morgan Stanley | Buy | $298 | 2025-10-02 | Overweight; Top Pick, PT raised in October 2025. | https://www.gurufocus.com/news/3129105/morgan-stanley-raises-apple-aapl-price-target-to-298-aapl-stock-news |
| JP Morgan | Buy | $305 | 2025-10-27 | Overweight; PT raised after results. | https://www.marketbeat.com/instant-alerts/jpmorgan-chase-co-issues-positive-forecast-for-apple-nasdaqaapl-stock-price-2025-10-27/ |
| Bank of America | Buy | $320 | 2025-10-29 | Raised long‑term framework; reiterated Buy. | https://finance.yahoo.com/news/apple-stock-target-raised-bofa-135505743.html |
| Citigroup | Buy | $240 | 2025-05-02 | Maintained Buy; trimmed PT post-earnings. | https://www.investing.com/news/analyst-ratings/citi-cuts-apple-stock-price-target-to-240-maintains-buy-rating-93CH-4019006 |
| Wells Fargo | Buy | $290 | 2025-10-21 | Overweight; PT raised in October 2025. | https://www.gurufocus.com/news/3152412/aapl-wells-fargo-raises-price-target-to-290-maintains-overweight-rating-aapl-stock-news |
Consensus View - Rating: Buy, Target Price: ~$296 (simple average of listed targets) - Strong Buy/Overweight skew across the six banks; BAC and GS at $320 top the range.
MSFT - Microsoft Corp.
Consensus Buy/Overweight with multiple PT increases tied to Azure and AI/Copilot momentum; WFC now among highest at $700.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $480 | 2025-05-01 | Raised PT; upbeat on AI and Azure growth. | https://www.investing.com/news/analyst-ratings/goldman-sachs-lifts-microsoft-stock-price-target-to-480-93CH-4015772 |
| Morgan Stanley | Buy | $625 | 2025-09-26 | Overweight; Top Pick in large-cap software. | https://www.investing.com/news/analyst-ratings/microsoft-stock-price-target-raised-to-625-from-582-at-morgan-stanley-93CH-4256920 |
| JP Morgan | Buy | $475 | 2025-05-01 | Overweight; PT increased after FQ3 beat. | https://www.investing.com/news/analyst-ratings/jpmorgan-raises-microsoft-stock-price-target-to-475-4015871 |
| Bank of America | Buy | $585 | 2025-07-18 | Raised PT into FQ4; AI/partner checks supportive. | https://www.investing.com/news/analyst-ratings/bofa-securities-raises-microsoft-stock-price-target-to-585-on-azure-strength-93CH-4142222 |
| Citigroup | Buy | $690 | 2025-10-30 | PT raised; maintains Buy. | https://www.gurufocus.com/news/3172856/msft-sees-price-target-increase-to-690-by-citigroup-maintaining-buy-rating-msft-stock-news |
| Wells Fargo | Buy | $700 | 2025-10-30 | Overweight; PT raised on sustained Azure growth. | https://www.investing.com/news/analyst-ratings/microsoft-stock-price-target-raised-to-700-from-675-at-wells-fargo-93CH-4318741 |
Consensus View - Rating: Buy, Target Price: ~$592 (simple average of listed targets) - All six positive; WFC and Citi are the high end.
GOOGL - Alphabet Inc.
Generally Buy/Overweight; BAC most bullish into October earnings on ads/AI; WFC more cautious (Equal Weight).
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $234 | 2025-09-03 | Reiterated Buy after search remedies decision. | https://www.investing.com/news/analyst-ratings/goldman-sachs-reiterates-buy-rating-on-alphabet-stock-amid-search-case-remedies-93CH-4221041 |
| Morgan Stanley | Buy | $205 | 2025-07-21 | Overweight; raised PT on innovation/productization. | https://www.investing.com/news/analyst-ratings/alphabet-stock-price-target-raised-to-205-from-185-at-morgan-stanley-4143076 |
| JP Morgan | Buy | $195 | 2025-05-21 | Overweight post Google I/O. | https://www.investing.com/news/analyst-ratings/jpmorgan-maintains-alphabet-stock-with-195-target-post-google-io-93CH-4056279 |
| Bank of America | Buy | $280 | 2025-10-20 | Raised PT on ad strength ahead of earnings. | https://www.investing.com/news/analyst-ratings/bofa-securities-raises-alphabet-stock-price-target-to-280-on-ad-strength-93CH-4296307 |
| Citigroup | Buy | $229 | 2025-03-18 | Maintained Buy; reiterated $229 target (Wiz announcement). | https://www.investing.com/news/analyst-ratings/citi-maintains-buy-on-alphabet-stock-reiterates-229-target-93CH-3935314 |
| Wells Fargo | Hold | $175 | 2025-05-21 | Equal Weight; awaiting deeper integration of AI in core search. | https://www.investing.com/news/analyst-ratings/wells-fargo-maintains-alphabet-stock-at-equal-weight-175-target-93CH-4056416 |
Consensus View - Rating: Buy, Target Price: ~$220 (simple average of listed targets) - Five Buys vs one Hold; BAC’s $280 is the bull case among covered banks.
AMZN - Amazon.com Inc.
Post–Q3 2025 wave of PT raises across the Street; six requested banks all positive/Overweight or Buy by late October.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $275 | 2025-10-03 | Raised PT on AWS growth outlook. | https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-amazon-stock-price-target-to-275-on-aws-growth-outlook-93CH-4270016 |
| Morgan Stanley | Buy | $315 | 2025-10-31 | Overweight; PT raised on results. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| JP Morgan | Buy | $305 | 2025-10-31 | Overweight; PT raised after beat. | https://www.marketbeat.com/instant-alerts/jpmorgan-chase-co-forecasts-strong-price-appreciation-for-amazoncom-nasdaqamzn-stock-2025-10-31/ |
| Bank of America | Buy | $303 | 2025-10-31 | PT raised; reiterated Buy. | https://www.marketbeat.com/instant-alerts/bank-of-america-issues-positive-forecast-for-amazoncom-nasdaqamzn-stock-price-2025-10-31/ |
| Citigroup | Buy | $320 | 2025-10-31 | PT raised; maintained Buy. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Wells Fargo | Buy | $292 | 2025-10-31 | Overweight; PT raised post-earnings. | https://www.marketbeat.com/instant-alerts/amazoncom-nasdaqamzn-given-new-29200-price-target-at-wells-fargo-company-2025-10-31/ |
Consensus View - Rating: Buy, Target Price: ~$302 (simple average of listed targets) - Unanimous positive stance with PTs clustered around $300.
NVDA - NVIDIA Corp.
All six banks positive/Overweight or Buy through late 2025; WFC and BAC raised targets into November amid continued AI demand.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $240 | 2025-10-31 | Raised PT; expects beat‑and‑raise and strong DC visibility. | https://finance.yahoo.com/news/goldman-sachs-expects-nvidia-beat-135658622.html |
| Morgan Stanley | Buy | $160 | 2025-05-19 | Overweight; reiterated Top Pick ahead of earnings earlier in year. | https://www.investing.com/news/analyst-ratings/morgan-stanley-maintains-nvidia-stock-overweight-rating-160-target-93CH-4053152 |
| JP Morgan | Buy | $170 | 2025-02-27 | Overweight; reiterated after results and guidance. | https://www.investing.com/news/analyst-ratings/jpmorgan-maintains-nvidia-stock-overweight-with-170-target-93CH-3896874 |
| Bank of America | Buy | $275 | 2025-10-29 | Raised PT; reiterated top‑sector pick on AI dominance. | https://finance.yahoo.com/news/analysts-lift-nvidia-price-targets-121925397.html |
| Citigroup | Buy | $190 | 2025-07- | PT raised on sovereign‑AI demand. | https://www.investopedia.com/nvidia-stock-gets-price-target-bump-from-citi-on-sovereign-ai-demand-surge-11767497 |
| Wells Fargo | Buy | $265 | 2025-11-14 | Overweight; PT raised on hyperscale DC momentum. | https://www.gurufocus.com/news/3209758/wells-fargo-raises-nvidia-nvda-price-target-to-265-nvda-stock-news |
Consensus View - Rating: Buy, Target Price: ~$217 (simple average of listed targets) - Banks remain constructive; BAC and WFC are the most bullish into year‑end.
META - Meta Platforms Inc.
Street remains bullish despite heavier AI capex; multiple PTs trimmed slightly after Q3, but still high-700s to 800s.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $815 | 2025-10-30 | PT lowered from $870 post‑Q3; stance remains Buy. | https://www.investing.com/news/analyst-ratings/goldman-sachs-lowers-meta-stock-price-target-to-815-on-investment-cycle-93CH-4317852 |
| Morgan Stanley | Buy | $750 | 2025-07-21 | Overweight; PT raised mid‑year. | https://www.investing.com/news/analyst-ratings/meta-platforms-stock-price-target-raised-to-750-by-morgan-stanley-4143078 |
| JP Morgan | Buy | $875 | 2025-07-31 | Overweight; raised PT after strong Q2. | https://www.investing.com/news/analyst-ratings/meta-platforms-stock-price-target-raised-to-875-from-795-at-jpmorgan-4163780 |
| Bank of America | Buy | $810 | 2025-10-30 | Lowered from $900 post‑Q3; remains Buy. | https://www.investing.com/news/analyst-ratings/bofa-securities-lowers-meta-stock-price-target-to-810-from-900-93CH-4318011 |
| Citigroup | Buy | $850 | 2025-10-30 | Recent trim from $915 per MarketBeat; still Buy. | https://www.marketbeat.com/instant-alerts/citigroup-has-lowered-expectations-for-meta-platforms-nasdaqmeta-stock-price-2025-10-30/ |
| Wells Fargo | Buy | $802 | 2025-10-30 | Overweight; PT cut post‑Q3. | https://www.marketbeat.com/instant-alerts/meta-platforms-nasdaqmeta-price-target-cut-to-80200-by-analysts-at-wells-fargo-company-2025-10-30/ |
Consensus View - Rating: Buy, Target Price: ~$817 (simple average of listed targets) - All six positive; targets cluster around $800 despite capex concerns.
TSLA - Tesla Inc.
Views are mixed; MS/GS/BAC targets rose into late 2025, while JPM and WFC remain clearly bearish. Net read skews to Neutral/Hold.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Hold | $400 | 2025-10-26 | Neutral; PT cut from $425. | https://www.marketbeat.com/instant-alerts/the-goldman-sachs-group-lowers-tesla-nasdaqtsla-price-target-to-40000-2025-10-26/ |
| Morgan Stanley | Buy | $410 | 2025-05-20 | Overweight; reiterated on long‑term autonomy/AI optionality. | https://www.investing.com/news/analyst-ratings/morgan-stanley-maintains-tesla-stock-overweight-with-410-target-4054469 |
| JP Morgan | Sell | $120 | 2025-03-12 | Underweight; cut PT on deliveries/brand damage concerns. | https://www.reuters.com/business/autos-transportation/jpmorgan-cuts-price-target-tesla-shares-brokerage-expects-lower-deliveries-2025-03-12/ |
| Bank of America | Hold | $471 | 2025-10-29 | Neutral; SOTP lifts PT; valuation still stretched. | https://finviz.com/news/213927/bank-of-america-raises-tesla-tsla-pt-to-471-maintains-neutral-rating |
| Citigroup | Hold | $180 | 2025-04- | Maintains Neutral; trimmed PT after Q1 miss/early Q2 datapoints. | https://www.marketscreener.com/quote/stock/TESLA-INC-6344549/news/Citigroup-Cuts-Tesla-Price-Target-to-180-From-196-Maintains-Neutral-Rating-46423628/ |
| Wells Fargo | Sell | $120 | 2025-06-09 | Underweight; sees downside on weak fundamentals and margin pressure. | https://price-target.com/2025/06/09/158213/ |
Consensus View - Rating: Hold, Target Price: ~$284 (simple average of listed targets) - Wide dispersion: MS/BAC above $400 vs JPM/WFC at $120; GS Neutral near $400.
AVGO - Broadcom Inc.
Uniformly bullish across banks tracked; banks lifted PTs through Sep/Oct on custom AI silicon and networking strength.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $360 | 2025-09-05 | Reiterated Buy; AI growth driving upside. | https://www.investing.com/news/analyst-ratings/broadcom-stock-holds-buy-rating-at-goldman-sachs-on-ai-momentum-93CH-4226196 |
| Morgan Stanley | Buy | $270 | 2025-06-06 | Overweight; target raised on AI traction. | https://www.investing.com/news/analyst-ratings/morgan-stanley-raises-broadcom-stock-price-target-citing-ai-growth-93CH-4084614 |
| JP Morgan | Buy | $400 | 2025-09-05 | Overweight; PT raised to $400. | https://www.investing.com/news/analyst-ratings/jpmorgan-raises-broadcom-stock-price-target-to-400-from-325-93CH-4226521 |
| Bank of America | Buy | $400 | 2025-09-05 | Raised PT on accelerating custom AI chip growth. | https://www.investing.com/news/analyst-ratings/bofa-securities-raises-broadcom-stock-price-target-to-400-on-ai-growth-93CH-4226065 |
| Citigroup | Buy | $415 | 2025-10-14 | PT lifted; maintains Buy. | https://www.gurufocus.com/news/3142795/citigroup-raises-price-target-for-avgo-to-415-maintains-buy-rating-avgo-stock-news |
| Wells Fargo | - | - | - | No recent public WFC AVGO target found. | - |
Consensus View - Rating: Buy, Target Price: ~$369 (simple average of available targets) - All covered banks positive; JP Morgan/BAC at $400 and Citi at $415 lead the range.
TSM - Taiwan Semiconductor Manufacturing Company Limited (TSMC)
Strong Buy/Overweight bias on multi‑year AI node leadership and price power; targets quoted mainly in NT$.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | NT$1,355 | 2025-01-05 | Conviction Buy; raised on advanced‑node pricing power. | https://www.investing.com/news/analyst-ratings/taiwan-semiconductor-stock-favored-as-pricing-power-strengthens-in-advanced-nodes-93CH-3796295 |
| Morgan Stanley | Buy | NT$860 | 2024-04-18 | Overweight; older PT focused on pricing strategy (latest public figure found). | https://www.investing.com/news/company-news/morgan-stanley-maintains-tsmc-overweight-stock-rating-on-pricing-strategy-93CH-3385215 |
| JP Morgan | Buy | NT$1,500 | 2025-03-05 | Overweight; reiterated after U.S. fab expansion plans. | https://www.investing.com/news/analyst-ratings/jpmorgan-maintains-tsmc-stock-overweight-twd1500-target-93CH-3908014 |
| Bank of America | Buy | NT$1,600 (≈US$330) | 2025-10-07 | Raised PT on improved pricing outlook and stronger visibility. | https://ph.investing.com/news/stock-market-news/bofa-raises-tsmc-target-sees-improved-pricing-outlook-2027108 |
| Citigroup | - | - | - | No recent public Citi TSM target identified in this period. | - |
| Wells Fargo | - | - | - | No recent public WFC TSM target identified. | - |
Consensus View - Rating: Buy, Target Price: ~NT$1,329 (simple average of available NT$ targets) - Consensus Buy with BAC/JPM at the high end; MS figure is older but supportive.
Highlights
- AAPL: BAC and GS both at $320; WFC raised to $290 in October 2025.
- MSFT: WFC’s $700 and Citi’s $690 frame the high end; MS at $625 (Overweight).
- GOOGL: BAC raised to $280 into October earnings; WFC remains Equal Weight $175.
- AMZN: All six banks Buy/Overweight post‑Q3; consensus near $300.
- NVDA: WFC lifted to $265 (Nov 14, 2025); BAC to $275 (Oct 29, 2025).
- META: Despite heavier AI capex, all six are Buy/Overweight with average target ~ $817.
- TSLA: Split views—MS/BAC constructive, JPM/WFC bearish; consensus around $284 and Neutral/Hold.
- AVGO: Uniform Buy/Overweight; JPM/BAC $400 and Citi $415 highlight AI custom silicon momentum.
- TSM: Banks broadly Buy; BAC to NT$1,600 and JPM to NT$1,500 on AI node leadership.
Notes: Dates reflect publication dates of the cited research summaries; many banks distribute full reports behind paywalls, so reputable secondary sources are referenced. Where no credible public record was found for a given bank/ticker, fields are left null.
IPO Calendar
Timeframe: November 20, 2025 to December 20, 2025 (US equity markets)
The US IPO window is open but narrow into year‑end: bankers and trackers point to two viable December weeks (Dec 8 and Dec 15) following the SEC’s post‑shutdown restart, so most issuers either rush to price in that span or slip to 1Q26. Activity skews toward a mix of small/micro‑cap deals and a few higher‑profile tech/space and crypto‑adjacent names. Bank and specialty finance listings have re‑emerged (e.g., Commercial Bancgroup in October; Central Bancompany now), while space tech (York Space Systems) and digital‑asset managers (Grayscale) are lining up. Overall 2025 issuance has rebounded versus 2024, but scheduling remains fluid due to the recent government shutdown backlog and holiday calendar effects.
Central Bancompany, Inc. (CBC)
- Expected listing date: 2025-11-20
- Price range: Priced at $21.00 (marketed $21–$24)
- Shares offered: 17.78 million shares (primary/secondary mix), 30‑day option customary
- Exchange: Nasdaq
- Lead underwriters: Morgan Stanley & Co. LLC, Keefe, Bruyette & Woods, Inc. (KBW), BofA Securities, Piper Sandler & Co., Stephens Inc.
- Business summary: Jefferson City, MO–based bank holding company with community banks and wealth units across MO, KS, OK, CO, and FL; ~$19.2B in balance‑sheet assets and ~$15.4B in wealth assets under advice at IPO, positioning for public‑market access and strategic flexibility.
- Notes: Final terms: $21.00 per share for gross proceeds of ~$373.3M; trades on Nov 20, 2025 under CBC. Underwriter line‑up per company/filing; sizing/take‑up of the over‑allotment not yet disclosed at pricing.
- Sources: Reuters – Central Bancompany raises $373 million in US IPO (Nov 19, 2025), Central Bancompany – Files Registration Statement for Proposed IPO (underwriters named)
Libera Gaming Operations, Inc. (LBRJ)
- Expected listing date: 2025-11-21
- Price range: $4.00 – $6.00 (illustrative midpoint $4.00 used in latest F‑1/A)
- Shares offered: 1,250,000 common shares (+187,500 over‑allotment option)
- Exchange: Nasdaq Capital Market (applied)
- Lead underwriters: Craft Capital Management LLC (Representative)
- Business summary: Japan‑based operator of 11 pachinko/pachislot halls with an ancillary Tokyo‑focused real‑estate arm; proceeds intended for growth initiatives and corporate purposes. Micro‑cap US listing to broaden capital access.
- Notes: Timing and venue subject to effectiveness and final exchange approval; prior filings referenced NYSE American, but the Nov 3, 2025 F‑1/A applies for Nasdaq Capital Market. Underwriter named as Craft Capital in SEC exhibits; additional co‑managers, if any, not confirmed.
- Sources: SEC – Libera Gaming Operations F‑1/A (Nov 3, 2025), SEC – Exhibit 5.1 referencing Craft Capital as Underwriter
Regentis Biomaterials Ltd. (RGNT)
- Expected listing date: TBD (late Nov/Dec 2025, subject to effectiveness)
- Price range: $10.00 – $12.00
- Shares offered: 1,000,000 ordinary shares (+15% over‑allotment)
- Exchange: NYSE American (approved)
- Lead underwriters: ThinkEquity LLC (sole book‑runner)
- Business summary: Israel‑based regenerative‑medicine company developing GelrinC, a cell‑free hydrogel implant for knee cartilage repair; CE‑marked in Europe with a US PMA pivotal trial ongoing. IPO proceeds earmarked for clinical, regulatory, and operating needs.
- Notes: Calendar indications around Nov 19 slipped; deal remains eligible to launch once the registration becomes effective and logistics finalize. Exchange per Oct 24, 2025 F‑1/A; earlier third‑party calendars showed Nasdaq, which is outdated.
- Sources: SEC – Regentis Biomaterials F‑1/A (Oct 24, 2025), Renaissance Capital note on filing/terms (Mar 11, 2025), StockAnalysis calendar snapshot (context)
York Space Systems, Inc. (YSS)
- Expected listing date: Targeting the December window (week of Dec 8 or Dec 15, 2025; subject to SEC process)
- Exchange: NYSE
- Lead underwriters: Goldman Sachs & Co. LLC, Jefferies LLC, Wells Fargo Securities, LLC
- Business summary: Denver‑based satellite platform manufacturer serving government and commercial customers (including US DoD); filed to go public with strong 9M25 revenue growth and improving losses; AE Industrial Partners is the majority owner.
- Notes: Terms (price range/shares) not yet set. Reuters and bankers expect most year‑end pricings to cluster in the weeks of Dec 8 and Dec 15; timing contingent on SEC clearance and market conditions.
- Sources: Reuters – York Space Systems files for US IPO; revenue up 59% (Nov 17, 2025)
Klook Technology Limited (KLK)
- Expected listing date: Potentially December 2025 (TBD; subject to SEC review)
- Exchange: NYSE
- Lead underwriters: Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC
- Business summary: APAC’s leading ‘experiences’ and travel‑activities platform; filed an F‑1 to list ADSs in New York to fund growth and expand globally.
- Notes: Filed Nov 10, 2025; final terms and launch date pending. Media reports suggest a $300–$500M raise, but sizing remains unofficial until the F‑1/A sets terms.
- Sources: Klook Newsroom – Files Registration Statement for Proposed IPO (Nov 10, 2025), Bloomberg – SoftBank‑backed Klook files for US IPO (Nov 10, 2025)
Grayscale Investments, LLC (GRAY)
- Expected listing date: TBD (aiming for late 2025 or early 2026; could move if SEC backlog persists)
- Exchange: NYSE
- Lead underwriters: Morgan Stanley & Co. LLC, BofA Securities, Inc., Jefferies LLC, Cantor Fitzgerald & Co.
- Business summary: Crypto‑asset manager behind GBTC and multiple crypto ETFs, pursuing a traditional IPO amid a friendlier US regulatory environment; 9M25 revenue $318.7M, net income $203.3M per S‑1.
- Notes: Filed publicly Nov 13, 2025; terms not yet set. Timing depends on SEC review cadence and market window; one of the first issuers to file with updated Q3 numbers post‑shutdown.
- Sources: Reuters – Grayscale makes US IPO filing public; revenue detail (Nov 13, 2025), CoinDesk – Grayscale files S‑1 for US IPO (Nov 13, 2025)
Once Upon a Farm PBC (OFRM)
- Expected listing date: TBD (market talk points to a possible 4Q25 window; may slip to 1Q26)
- Exchange: NYSE
- Lead underwriters: Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, BofA Securities, Inc., William Blair & Company, L.L.C.
- Business summary: US organic baby and kids food brand co‑founded by Jennifer Garner; filed with strong 1H25 revenue growth to scale distribution, brand, and product innovation via public‑market capital.
- Notes: Confidentially filed in June; public filing in late September. No terms yet; timing subject to SEC review and market window into December.
- Sources: Reuters – Once Upon a Farm files US IPO; underwriters and revenue disclosed (Sept 29, 2025), Reuters – Confidential filing report (June 18, 2025), CNBC – Company confirms NYSE ticker OFRM (Sept 29, 2025)
IPO calendars are inherently fluid. US IPOs are typically set 7–10 days ahead and can be accelerated, delayed, resized, or withdrawn; micro‑cap deals in particular may change on short notice. The SEC’s recent backlog and holiday trading calendar increase scheduling uncertainty; treat expected dates as best‑effort indications until a company prices its deal and the exchange posts a final listing notice.
Sources
- Stock Ratings: https://finance.yahoo.com/news/analysts-lift-nvidia-price-targets-121925397.html, https://finance.yahoo.com/news/apple-stock-target-raised-bofa-135505743.html, https://finance.yahoo.com/news/goldman-sachs-expects-nvidia-beat-135658622.html, https://finviz.com/news/213927/bank-of-america-raises-tesla-tsla-pt-to-471-maintains-neutral-rating, https://ph.investing.com/news/stock-market-news/bofa-raises-tsmc-target-sees-improved-pricing-outlook-2027108, https://price-target.com/2025/06/09/158213/, https://www.gurufocus.com/news/3129105/morgan-stanley-raises-apple-aapl-price-target-to-298-aapl-stock-news, https://www.gurufocus.com/news/3142795/citigroup-raises-price-target-for-avgo-to-415-maintains-buy-rating-avgo-stock-news, https://www.gurufocus.com/news/3152412/aapl-wells-fargo-raises-price-target-to-290-maintains-overweight-rating-aapl-stock-news, https://www.gurufocus.com/news/3172856/msft-sees-price-target-increase-to-690-by-citigroup-maintaining-buy-rating-msft-stock-news, https://www.gurufocus.com/news/3175717/goldman-sachs-raises-price-target-for-apple-aapl-to-320-aapl-stock-news, https://www.gurufocus.com/news/3209758/wells-fargo-raises-nvidia-nvda-price-target-to-265-nvda-stock-news, https://www.investing.com/news/analyst-ratings/alphabet-stock-price-target-raised-to-205-from-185-at-morgan-stanley-4143076, https://www.investing.com/news/analyst-ratings/bofa-securities-lowers-meta-stock-price-target-to-810-from-900-93CH-4318011, https://www.investing.com/news/analyst-ratings/bofa-securities-raises-alphabet-stock-price-target-to-280-on-ad-strength-93CH-4296307, https://www.investing.com/news/analyst-ratings/bofa-securities-raises-broadcom-stock-price-target-to-400-on-ai-growth-93CH-4226065, https://www.investing.com/news/analyst-ratings/bofa-securities-raises-microsoft-stock-price-target-to-585-on-azure-strength-93CH-4142222, https://www.investing.com/news/analyst-ratings/broadcom-stock-holds-buy-rating-at-goldman-sachs-on-ai-momentum-93CH-4226196, https://www.investing.com/news/analyst-ratings/citi-cuts-apple-stock-price-target-to-240-maintains-buy-rating-93CH-4019006, https://www.investing.com/news/analyst-ratings/citi-maintains-buy-on-alphabet-stock-reiterates-229-target-93CH-3935314, https://www.investing.com/news/analyst-ratings/goldman-sachs-lifts-microsoft-stock-price-target-to-480-93CH-4015772, https://www.investing.com/news/analyst-ratings/goldman-sachs-lowers-meta-stock-price-target-to-815-on-investment-cycle-93CH-4317852, https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-amazon-stock-price-target-to-275-on-aws-growth-outlook-93CH-4270016, https://www.investing.com/news/analyst-ratings/goldman-sachs-reiterates-buy-rating-on-alphabet-stock-amid-search-case-remedies-93CH-4221041, https://www.investing.com/news/analyst-ratings/jpmorgan-maintains-alphabet-stock-with-195-target-post-google-io-93CH-4056279, https://www.investing.com/news/analyst-ratings/jpmorgan-maintains-nvidia-stock-overweight-with-170-target-93CH-3896874, https://www.investing.com/news/analyst-ratings/jpmorgan-maintains-tsmc-stock-overweight-twd1500-target-93CH-3908014, https://www.investing.com/news/analyst-ratings/jpmorgan-raises-broadcom-stock-price-target-to-400-from-325-93CH-4226521, https://www.investing.com/news/analyst-ratings/jpmorgan-raises-microsoft-stock-price-target-to-475-4015871, https://www.investing.com/news/analyst-ratings/meta-platforms-stock-price-target-raised-to-750-by-morgan-stanley-4143078, https://www.investing.com/news/analyst-ratings/meta-platforms-stock-price-target-raised-to-875-from-795-at-jpmorgan-4163780, https://www.investing.com/news/analyst-ratings/microsoft-stock-price-target-raised-to-625-from-582-at-morgan-stanley-93CH-4256920, https://www.investing.com/news/analyst-ratings/microsoft-stock-price-target-raised-to-700-from-675-at-wells-fargo-93CH-4318741, https://www.investing.com/news/analyst-ratings/morgan-stanley-maintains-nvidia-stock-overweight-rating-160-target-93CH-4053152, https://www.investing.com/news/analyst-ratings/morgan-stanley-maintains-tesla-stock-overweight-with-410-target-4054469, https://www.investing.com/news/analyst-ratings/morgan-stanley-raises-broadcom-stock-price-target-citing-ai-growth-93CH-4084614, https://www.investing.com/news/analyst-ratings/taiwan-semiconductor-stock-favored-as-pricing-power-strengthens-in-advanced-nodes-93CH-3796295, https://www.investing.com/news/analyst-ratings/wells-fargo-maintains-alphabet-stock-at-equal-weight-175-target-93CH-4056416, https://www.investing.com/news/company-news/morgan-stanley-maintains-tsmc-overweight-stock-rating-on-pricing-strategy-93CH-3385215, https://www.investopedia.com/nvidia-stock-gets-price-target-bump-from-citi-on-sovereign-ai-demand-surge-11767497, https://www.marketbeat.com/instant-alerts/amazoncom-nasdaqamzn-given-new-29200-price-target-at-wells-fargo-company-2025-10-31/, https://www.marketbeat.com/instant-alerts/bank-of-america-issues-positive-forecast-for-amazoncom-nasdaqamzn-stock-price-2025-10-31/, https://www.marketbeat.com/instant-alerts/citigroup-has-lowered-expectations-for-meta-platforms-nasdaqmeta-stock-price-2025-10-30/, https://www.marketbeat.com/instant-alerts/jpmorgan-chase-co-forecasts-strong-price-appreciation-for-amazoncom-nasdaqamzn-stock-2025-10-31/, https://www.marketbeat.com/instant-alerts/jpmorgan-chase-co-issues-positive-forecast-for-apple-nasdaqaapl-stock-price-2025-10-27/, https://www.marketbeat.com/instant-alerts/meta-platforms-nasdaqmeta-price-target-cut-to-80200-by-analysts-at-wells-fargo-company-2025-10-30/, https://www.marketbeat.com/instant-alerts/the-goldman-sachs-group-lowers-tesla-nasdaqtsla-price-target-to-40000-2025-10-26/, https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/, https://www.marketscreener.com/quote/stock/TESLA-INC-6344549/news/Citigroup-Cuts-Tesla-Price-Target-to-180-From-196-Maintains-Neutral-Rating-46423628/, https://www.reuters.com/business/autos-transportation/jpmorgan-cuts-price-target-tesla-shares-brokerage-expects-lower-deliveries-2025-03-12/
Disclaimer
This research report is for informational purposes only and does not constitute investment advice. All information is sourced from publicly available data and should be verified independently. Past performance does not guarantee future results.
Generated on: 2025-11-20 at 11:14 UTC
Source: Alpha Signal Monitor - Automated Research System
Contact: For questions about this report, please contact your Alpha Signal Monitor administrator.
Powered by Alpha Signal Monitor | Market Intelligence Through AI